Literature DB >> 11574558

Molecular characterization of Cryptosporidium isolates obtained from humans in France.

K Guyot1, A Follet-Dumoulin, E Lelièvre, C Sarfati, M Rabodonirina, G Nevez, J C Cailliez, D Camus, E Dei-Cas.   

Abstract

Cryptosporidium parvum is usually considered the agent of human cryptosporidiosis. However, only in the last few years, molecular biology-based methods have allowed the identification of Cryptosporidium species and genotypes, and only a few data are available from France. In the present work, we collected samples of whole feces from 57 patients from France (11 immunocompetent patients, 35 human immunodeficiency virus [HIV]-infected patients, 11 immunocompromised but non-HIV-infected patients) in whom Cryptosporidium oocysts were recognized by clinical laboratories. A fragment of the Cryptosporidium 18S rRNA gene encompassing the hypervariable region was amplified by PCR and sequenced. The results revealed that the majority of the patients were infected with cattle (29 of 57) or human (18 of 57) genotypes of Cryptosporidium parvum. However, a number of immunocompromised patients were infected with C. meleagridis (3 of 57), C. felis (6 of 57), or a new genotype of C. muris (1 of 57). This is the first report of the last three species of Cryptosporidium in humans in France. These results indicate that immunocompromised individuals are susceptible to a wide range of Cryptosporidium species and genotypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574558      PMCID: PMC88374          DOI: 10.1128/JCM.39.10.3472-3480.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Which genotypes/species of Cryptosporidium are humans susceptible to?

Authors:  U Morgan; L Xiao; I Sulaiman; R Weber; A A Lal; R C Thompson; P Deplazes
Journal:  J Eukaryot Microbiol       Date:  1999 Sep-Oct       Impact factor: 3.346

2.  Separation of Cryptosporidium species oocysts from feces by using a percoll discontinuous density gradient.

Authors:  E Waldman; S Tzipori; J R Forsyth
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Sporadic cryptosporidiosis in children.

Authors:  D P Casemore; B Jackson
Journal:  Lancet       Date:  1983-09-17       Impact factor: 79.321

4.  Genotyping human and bovine isolates of Cryptosporidium parvum by polymerase chain reaction-restriction fragment length polymorphism analysis of a repetitive DNA sequence.

Authors:  A Bonnin; M N Fourmaux; J F Dubremetz; R G Nelson; P Gobet; G Harly; M Buisson; D Puygauthier-Toubas; G Gabriel-Pospisil; M Naciri; P Camerlynck
Journal:  FEMS Microbiol Lett       Date:  1996-04-01       Impact factor: 2.742

5.  Molecular characterization of Cryptosporidium isolates from humans and other animals using random amplified polymorphic DNA analysis.

Authors:  U M Morgan; C C Constantine; P O'Donoghue; B P Meloni; P A O'Brien; R C Thompson
Journal:  Am J Trop Med Hyg       Date:  1995-06       Impact factor: 2.345

Review 6.  Cryptosporidium species a "new" human pathogen.

Authors:  D P Casemore; R L Sands; A Curry
Journal:  J Clin Pathol       Date:  1985-12       Impact factor: 3.411

7.  A 2359-base pair DNA fragment from Cryptosporidium parvum encoding a repetitive oocyst protein.

Authors:  N C Lally; G D Baird; S J McQuay; F Wright; J J Oliver
Journal:  Mol Biochem Parasitol       Date:  1992-11       Impact factor: 1.759

8.  Gastro-enteritis due to Cryptosporidium: a prospective survey in a children's hospital.

Authors:  C A Hart; D Baxby; N Blundell
Journal:  J Infect       Date:  1984-11       Impact factor: 6.072

9.  Identification of genetic heterogeneity in the Cryptosporidium parvum ribosomal repeat.

Authors:  M Carraway; S Tzipori; G Widmer
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

10.  Differentiation between human and animal strains of Cryptosporidium parvum using isoenzyme typing.

Authors:  F M Awad-el-Kariem; H A Robinson; D A Dyson; D Evans; S Wright; M T Fox; V McDonald
Journal:  Parasitology       Date:  1995-02       Impact factor: 3.234

View more
  61 in total

1.  Evaluation of recombinant oocyst protein CP41 for detection of cryptosporidium-specific antibodies.

Authors:  Sonia A Kjos; Mark Jenkins; Pablo C Okhuysen; Cynthia L Chappell
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

2.  Viability staining and animal infectivity of Cryptosporidium andersoni oocysts after long-term storage.

Authors:  Martin Kvác; Dana Kvetonová; Jirí Salát; Oleg Ditrich
Journal:  Parasitol Res       Date:  2006-10-06       Impact factor: 2.289

3.  Incidence of cryptosporidiosis species in paediatric patients in Malawi.

Authors:  T D Morse; R A B Nichols; A M Grimason; B M Campbell; K C Tembo; H V Smith
Journal:  Epidemiol Infect       Date:  2007-01-15       Impact factor: 2.451

4.  Cryptosporidium meleagridis: infectivity in healthy adult volunteers.

Authors:  Cynthia L Chappell; Pablo C Okhuysen; Rebecca C Langer-Curry; Donna E Akiyoshi; Giovanni Widmer; Saul Tzipori
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

5.  Identification of a high diversity of Cryptosporidium species genotypes and subtypes in a pediatric population in Nigeria.

Authors:  Síle F Molloy; Huw V Smith; Patrick Kirwan; Rosely A B Nichols; Samuel O Asaolu; Lisa Connelly; Celia V Holland
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

6.  Detection of cryptosporidium and identification to the species level by nested PCR and restriction fragment length polymorphism.

Authors:  Stephane Coupe; Claudine Sarfati; Samia Hamane; Francis Derouin
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Identification of Cryptosporidium spp. oocysts in United Kingdom noncarbonated natural mineral waters and drinking waters by using a modified nested PCR-restriction fragment length polymorphism assay.

Authors:  R A B Nichols; B M Campbell; H V Smith
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

8.  Electrophoretic analysis of genetic variability within Cryptosporidium parvum from imported and autochthonous cases of human cryptosporidiosis in the United Kingdom.

Authors:  R B Gasser; Y G Abs El-Osta; R M Chalmers
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

9.  Host-adapted Cryptosporidium spp. in Canada geese (Branta canadensis).

Authors:  Ling Zhou; Hailu Kassa; Monica L Tischler; Lihua Xiao
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

10.  Integrated mapping, chromosomal sequencing and sequence analysis of Cryptosporidium parvum.

Authors:  Alan T Bankier; Helen F Spriggs; Berthold Fartmann; Bernard A Konfortov; Martin Madera; Christine Vogel; Sarah A Teichmann; Al Ivens; Paul H Dear
Journal:  Genome Res       Date:  2003-07-17       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.